How we use electronic monitoring at Canadian Blood Services
Following legislation passed by the Government of Ontario requiring organizations in the province to notify employees about circumstances when they may be monitored electronically, we are implementing a national electronic monitoring policy effective Oct. 11, 2022. Simply put, this policy takes our existing practices and puts them into a single point of reference — nothing in the policy changes our current practices and all current safeguards and rules regarding access and use of employee information remain in place. Visit Connect for more details and reach out to your PCP business partner if you have any questions or concerns.
Town hall Wednesday, Oct. 26: Call for questions
Our next live town hall event is coming up Wednesday, Oct. 26, 1–2 p.m. ET. Please submit questions in advance to firstname.lastname@example.org with the subject line ‘TOWNHALL’ or use this anonymous form. You can also submit questions live during the event after joining with the meeting link in your Outlook invitation. We’ve seen great engagement prior and during the townhall events. Due to the large number of questions received, it may not always be possible to get to every inquiry, however we strive to provide responses through Your Digest, Connect or by emailing you directly if a name is included with the question.
Upcoming DEI workshops: Building inclusive workplaces and disability inclusion
An inclusive workplace is an environment that actively promotes a sense of belonging and makes every employee feel valued. Join the diversity, equity and inclusion division for Building Inclusive Workplaces on Oct. 28 (12–1:30 p.m. ET). The session is aimed at helping participants gain a deeper understanding of how to become a strong ally and upstander, and how to foster a psychologically safe workplace. Then, on Oct. 31 (12–1:00 p.m. ET) in recognition of Disability Employment Awareness Month, join us for a workshop on Disability Inclusion. During this session, participants will examine some of the barriers specific to disability inclusion that exist and how we can create a culture of belonging.
Register for a live learning workshop: EDA overview
Need a 101 on Employee Direct Access (EDA)? Join us on Oct. 25, 11 a.m. ET or Oct. 27, 1 p.m. ET for a live virtual workshop on how to use the app — including how to access pay information, submit leave requests and tips and tricks to enhance your employee experience with the platform. Register here and learn more about our other live learning offerings on Connect.
Thanks to a stem cell donor, a father-son bond endures and evolves
Being a great dad can take so many forms over a lifetime. And Tom Wong is grateful for each new one, especially the opportunities made possible by a stem cell donor. Thanks to that donor, Tom is helping his son, Forrest, navigate the challenges of young adulthood — and experiencing the joy of learning from him, too. “He helps me do things I’m not skilled to do, and I help him with things he’s not skilled to do,” says Tom. “We rely on each other. He’s just a great kid.” Stories like Tom’s show us how donors really do make all the difference, the powerful idea at the heart of our new creative platform. Read more about him on blood.ca and share with others in your network.
Question of the day
Is there any role for Canadian Blood Services in Grifols operations (e.g., quality of plasma collection and manufacturing)?
Through the agreement, Canadian Blood Services will approve where Grifols opens its new centres in Canada. We will only approve locations that will not directly compete with our network of blood and plasma donor centres. Our site selection criteria for plasma donor centres generally includes factors such as population size, proximity to shopping and post-secondary institutions and access to public transit.
The agreement limits Grifols to collecting up to 25 per cent of the plasma required to make immunoglobulins. Canadian Blood Services will continue to expand our plasma collection programs to collect the remainder, as we work collaboratively with Grifols to achieve a minimum of 50 per cent plasma sufficiency for immunoglobulins in Canada.
The agreement also ensures Grifols uses plasma they collect in Canada to manufacture immunoglobulins for patients in Canada only. None of the immunoglobulins can be sold offshore.
It is also important to note that Health Canada is the regulator of blood and blood products in Canada, including plasma and plasma-derived medications. All blood and plasma collection centres in Canada, including Grifols’ collection centres and their manufacturing plant in Montreal, must obtain a license to operate from Health Canada and undergo regular inspections, like we do, to ensure compliance with federal legislation.